The results of the present study demonstrated that the percentages of macrophages in both the PM-2 K+CD14+ and PM-2 K+CD14− subsets were not different between patients with HER2-positive breast cancer and those with HER2-negative breast cancer. Here, CD14 is linked to breast cancer.